<DOC>
	<DOCNO>NCT00140361</DOCNO>
	<brief_summary>This ongoing monitoring activity efficacy sulfadoxine-pyrimethamine ( SP ) , current national treatment choice uncomplicated malaria Tanzania , combination SP artesunate among child &lt; 5 year 3 site rural Tanzania . Protocol amend 2004 ( 1 ) include lumefantrine+artemether , newly identify first-line treatment malaria introduce Tanzania 2006 ; ( 2 ) limit basis , include adult patient ; ( 3 ) extend follow-up 28 day ; ( 4 ) investigate whether treated bednets would reduce confound reinfection</brief_summary>
	<brief_title>Efficacy Sulphadoxine-pyrimethamine Artemisinin-containing Combination Therapy Malaria</brief_title>
	<detailed_description>This ongoing monitoring activity efficacy sulfadoxine-pyrimethamine ( SP ) , current national treatment choice uncomplicated malaria Tanzania , combination SP artesunate among child &lt; 5 year 3 site rural Tanzania . Protocol amend 2004 ( 1 ) include lumefantrine+artemether , newly identify first-line treatment malaria introduce Tanzania 2006 ; ( 2 ) limit basis , include adult patient ; ( 3 ) extend follow-up 28 day ; ( 4 ) investigate whether treated bednets would reduce confound reinfection</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<criteria>Children &lt; 5 year age ( one site , patient age eligible ) . Documented fever ( axillary temperature &gt; = 37.5oC ) absence another obvious cause fever serious chronic medical condition Unmixed infection P. falciparum 2,000 250,000 asexual parasites/mm3 Patients ' patient ' parent 's guardian 's informed consent willingness participate study Any evidence severe malaria would require hospitalization treatment . Reported allergy antimalarial drug , include sulfa artemisinin drug . History pregnancy delay menstrual period Breastfeeding child le 8 week age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>malaria</keyword>
	<keyword>sulfadoxine-pyrimethamine</keyword>
	<keyword>sulfadoxine-pyrimethamine plus artsunate</keyword>
	<keyword>lumefantrine plus artemether</keyword>
	<keyword>combination therapy</keyword>
</DOC>